Lifecore changes executive incentive from cash to stock for FY2024

LIFECORE BIOMEDICAL, INC. DE

CFO John D. Morberg and James G. Hall will receive FY2024 incentive in fully vested, unrestricted shares instead of cash.
Number of Bonus Shares equals cash incentive amount divided by fair market value on determination date.
Shares issued under 2019 Stock Incentive Plan; if insufficient reserves, pro rata issuance with contingent shareholder approval.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.